Publication | Closed Access

Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity

Improved ActivityBeta AmyloidNanoliquid CrystalsNano-drug DeliveryPharmacologyProtein NanoparticlesBiomolecular Engineering